Source comparison
IGF-1 vs IGF-1 LR3
IGF-1 LR3 constitutes an extra 13 amino acids in its structure than the regular IGF-1, thus giving it a longer half-life of approximately 20-30 hours. Because of its long half-life, it can remain in the blood circulation for longer hours can bind with the cell
This comparison does not assign a generated winner or score.
- IGF-1 LR3 constitutes an extra 13 amino acids in its structure than the regular IGF-1, thus giving it a longer half-life of approximately 20-30 hours.
- Because of its long half-life, it can remain in the blood circulation for longer hours can bind with the cell surface receptors known as IGF-1 more efficiently, and can activate cell growth more promptly.
- Due to the structural differences, IGF-1 LR3 has a lower affinity to insulin growth factor binding proteins (IGF-BP) compared to its parent compound called IGF-1. This makes IGF-1 LR3 more potent and pharmacologically strong.
- IGF-1 LR3 also ensures inhibits the entry of glucose into the cells which results in the utilization of fat by the body’s cells.
- A daily dosage of 20-50 mcg of IGF-1 LR3 is suggested by the physicians for a cycle of 6 to 7 weeks as desensitization may follow after that.